Could a simple inhaler ease COPD breathlessness?
NCT ID NCT06969573
First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times
Summary
This small pilot study tests whether an inhaled medication called Treprostinil can reduce breathlessness and improve exercise ability in people with mild COPD. Twenty participants will take either the drug or a placebo and undergo lung function tests, exercise tests, and imaging. The goal is to see if this approach is worth studying further.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Treprostinil (inhaled)
- What this could lead to
- If it works, this could point toward a new way to help people with mild COPD feel less breathless during activity and exercise more comfortably.
- What could go wrong
- This is a very small, early pilot study with only 20 people. It is designed mainly to test feasibility, not to prove effectiveness. The drug may not improve symptoms significantly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Physiology Laboratory
Edmonton, Alberta, T6G2R3, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could remote rehab keep COPD patients out of the hospital?
- Chest vibrations may boost lung sample collection
- Sports-Inspired balance training could help COPD patients avoid falls
- Can remote care tame COPD Flare-Ups?
- Can a biologic clear the clogged airways of COPD?
- Can animated videos boost Self-Care in lung disease better than paper brochures?